Maxia Pharmaceuticals, Inc. Trademark Details
Word Mark | Maxia Pharmaceuticals, Inc. |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Current Owner
Serial Number | 78154718 |
---|---|
Status Date | Friday, January 30, 2004 |
Filing Date | Friday, January 30, 2004 |
Attorney | Kathryn E. Swint |
Correspondent
Kathryn E. Swint
Arnall Golden Gregory LLP
1201 West Peachtree Street
Suite 2800
Atlanta GA 30309-3450
Arnall Golden Gregory LLP
1201 West Peachtree Street
Suite 2800
Atlanta GA 30309-3450
Case File Statements
Disclaimer with Predetermined Text | "Pharmaceutical, Inc." |
---|---|
Goods & Services | Pharmaceuticals, namely, compositions for the treatment of diabetes, inflammatory diseases, cancer and heart disease |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Thursday, September 5, 2002 |
Primary Code | 005 |
Trademark Timeline
-
Aug 15 2002Trademark application filed with USPTO
-
Jan 22 2003Assigned To Examiner
-
Jan 27 2003Non-Final Action Mailed
-
Jan 30 2003Correspondence Received In Law Office
-
Jan 30 2003Teas Response To Office Action Received
-
Mar 06 2003Approved For Pub - Principal Register
-
Apr 16 2003Notice of Publication
-
May 06 2003Published For Opposition
-
Jul 29 2003Noa Mailed - Sou Required From Applicant
-
Jun 04 2004Abandonment - No Use Statement Filed